Oncovin and Intracardiac thrombus - a phase IV clinical study of FDA data

Summary:

Intracardiac thrombus is reported only by a few people who take Oncovin.

The phase IV clinical study analyzes which people take Oncovin and have Intracardiac thrombus. It is created by eHealthMe based on reports of 6,006 people who have side effects while taking Oncovin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 26, 2022

6,006 people reported to have side effects when taking Oncovin.
Among them, 4 people (0.07%) have Intracardiac thrombus.


What is Oncovin?

Oncovin has active ingredients of vincristine sulfate. eHealthMe is studying from 6,013 Oncovin users for its effectiveness, alternative drugs and more.

What is Intracardiac thrombus?

Intracardiac thrombus (presence of a circumscribed mass with heart wall) is found to be associated with 863 drugs and 489 conditions by eHealthMe.

Number of Oncovin and Intracardiac thrombus reports submitted per year:

Could Oncovin cause Intracardiac thrombus?

Time on Oncovin when people have Intracardiac thrombus *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Intracardiac thrombus when taking Oncovin *:

  • female: 25 %
  • male: 75 %

Age of people who have Intracardiac thrombus when taking Oncovin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 50 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs people take besides Oncovin *:

  1. Dactinomycin: 2 people, 50.00%
  2. Xylocaine: 1 person, 25.00%
  3. Prednisolone: 1 person, 25.00%
  4. Povidone Iodine: 1 person, 25.00%
  5. Omnipaque 300: 1 person, 25.00%
  6. Kytril: 1 person, 25.00%
  7. Famotidine: 1 person, 25.00%
  8. Enalapril Maleate: 1 person, 25.00%
  9. Diflucan: 1 person, 25.00%
  10. Cyclophosphamide: 1 person, 25.00%

Common side effects people have besides Intracardiac thrombus *:

  1. Cardiac Failure: 2 people, 50.00%
  2. Pneumonia: 2 people, 50.00%
  3. Weakness: 1 person, 25.00%
  4. Heart Attack: 1 person, 25.00%
  5. Blast Crisis In Myelogenous Leukaemia: 1 person, 25.00%
  6. Breathing Difficulty: 1 person, 25.00%
  7. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 25.00%
  8. Chest Pain: 1 person, 25.00%
  9. Concomitant Disease Progression (progress in accompanying disease): 1 person, 25.00%
  10. Coronary Artery Restenosis (recurrence of narrowing of artery): 1 person, 25.00%

Common conditions people have *:

  1. Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 2 people, 50.00%
  2. Pain: 1 person, 25.00%
  3. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 1 person, 25.00%
  4. Lymphoma (cancer that begins in immune system cells): 1 person, 25.00%
  5. Anaesthesia: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Oncovin and have Intracardiac thrombus?

Check whether Intracardiac thrombus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Intracardiac thrombus and when was it recovered:

Expand to all the drugs that have ingredients of vincristine sulfate:

Alternative drugs to, pros and cons of Oncovin:

Common Oncovin side effects:

Browse all side effects of Oncovin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Intracardiac thrombus treatments and more:

COVID vaccines that are related to Intracardiac thrombus:

Common drugs associated with Intracardiac thrombus:

All the drugs that are associated with Intracardiac thrombus:

Common conditions associated with Intracardiac thrombus:

All the conditions that are associated with Intracardiac thrombus:

How the study uses the data?

The study uses data from the FDA. It is based on vincristine sulfate (the active ingredients of Oncovin) and Oncovin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: